Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2024-08-08 2024-07-11
Drug Identification Number 02434849 02434849
Brand name TEVA-ALMOTRIPTAN TEVA-ALMOTRIPTAN
Common or Proper name ALMOTRIPTAN 12.5MG TABS ALMOTRIPTAN 12.5MG TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ALMOTRIPTAN ALMOTRIPTAN
Strength(s) 12.5MG 12.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size PP6 PP6
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-06 2024-06-06
Estimated end date Unknown 2024-09-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Item is on Suspended Supply
Health Canada comments